M4MM
Glass House Brands Reports Q3 2025 Financial Results
LONG BEACH – Glass House Brands Inc. disclosed third-quarter 2025 earnings that showed a marked slowdown in sales and profitability, chalked up to deliberate shifts in its labor strategy. The company posted revenue of $38.4 ...
ANTG Inks Deal with Curaleaf to Supply Medical Cannabis for UK Patients
LONDON – Australian Natural Therapeutics Group, a leading cultivator of pharmaceutical-grade Cannabis, has reached an agreement with Curaleaf Laboratories to bring its products to British patients, marking a cross-continental push into Europe's second-largest medical Cannabis ...
Trump Signs Funding Measure Ending Historic 43-Day Government Shutdown, Bans Hemp-Derived THC Products
WASHINGTON – President Donald Trump signed a bipartisan spending package that reopens the federal government after a 43-day impasse, marking the longest such closure in American history. Tucked into the legislation, however, are new limits ...
NORML Calls for MORE Act Support to Transform Federal Cannabis Policy
LOS ANGELES – On August 29, a group of Democratic lawmakers reintroduced the Marijuana Opportunity Reinvestment and Expungement (MORE) Act (H.R. 5068). The legislation seeks to remove (deschedule) Cannabis entirely from the Controlled Substances Act ...
SHF Holdings Introduces Banking Solution for Cannabis Businesses and Financial Institutions
DENVER – SHF Holdings, Inc. operating as Safe Harbor Financial, has launched a new Fully Managed Cannabis Banking Program, designed to streamline financial services for banks and credit unions serving the regulated Cannabis industry. Announced ...
Canadian Legal Cannabis Industry Contributes $16 Billion to GDP in 2024, Report Reveals
TORONTO – A new report from Organigram Global Inc., in collaboration with the Canadian Chamber of Commerce, details the substantial economic role of Canada's legal Cannabis industry last year. The sector added more than $16 ...
Cultivation Sector Outshines Modest Cannabis Capital Drop, Viridian Capital Advisors Reports
LOS ANGELES – Capital raising in the Cannabis industry has dipped slightly this year, with year-to-date (YTD) totals reaching $1.54 billion as of September 2025, a 2.4% drop from $1.58 billion in the same period ...
Glass House Brands Reports Q3 2025 Financial Results
LONG BEACH – Glass House Brands Inc. disclosed third-quarter 2025 earnings that showed a marked slowdown in sales and profitability, chalked up to deliberate shifts in its labor strategy. The company posted revenue of $38.4 ...
ANTG Inks Deal with Curaleaf to Supply Medical Cannabis for UK Patients
LONDON – Australian Natural Therapeutics Group, a leading cultivator of pharmaceutical-grade Cannabis, has reached an agreement with Curaleaf Laboratories to bring its products to British patients, marking a cross-continental push into Europe's second-largest medical Cannabis ...
Trump Signs Funding Measure Ending Historic 43-Day Government Shutdown, Bans Hemp-Derived THC Products
WASHINGTON – President Donald Trump signed a bipartisan spending package that reopens the federal government after a 43-day impasse, marking the longest such closure in American history. Tucked into the legislation, however, are new limits ...
Clearmind Medicine Announces Promising Results in Obesity Treatment from Pre-Clinical Trial
Clearmind Medicine Inc. a biotech company at the forefront of developing novel psychedelic-derived therapeutics, has announced encouraging outcomes from its latest pre-clinical trial. The study, spearheaded by Professor Joseph Tam of The Hebrew University of ...
Cybin Inc. Unveils Promising Phase 2 Results for Psychedelic Depression Treatment CYB003
Cybin Inc. a psychedelic biotech drug development, has recently announced the comprehensive results from its Phase 2 trial of CYB003, a groundbreaking treatment for Major Depressive Disorder (MDD). These findings, presented at a high-profile R&D ...
Venture West Secures $17.5 Million Refinance Loan for Cannabis Firm Cal Grow’s Headquarters
LOS ANGELES- In a significant move underscoring the growing financial robustness of the cannabis industry, Venture West Funding, a California commercial mortgage broker, has successfully arranged a $17.5 million refinance loan for Cal Grow, a ...
Oregon’s Cannabis Market Faces Oversupply Challenges Amid Regulatory Complexities
LOS ANGELES- Oregon, a state known for its progressive stance on cannabis, is currently grappling with significant oversupply issues in its market. This challenge is compounded by various other difficulties that have been persisting in ...
University of Utah Launches Medical Cannabis Research Center
LOS ANGELES- The University of Utah is taking a significant step forward in the realm of medical cannabis research with the establishment of the Center for Medical Cannabis Research (CMCR). Announced on November 21, this ...
Numinus Wellness Inc. Announces Fourth Quarter and Full Year Fiscal 2023 Results
LOS ANGELES- Numinus Wellness Inc. has announced its financial results for the fourth quarter and the full year of fiscal 2023, highlighting significant revenue growth and strategic advancements in its operations. Fourth Quarter Fiscal 2023 ...
New York Cannabis Control Board Approves Settlement
NEW YORK- In a pivotal decision this week, the New York Cannabis Control Board resolved a lawsuit brought by military veterans, unlocking the way for over 400 adult-use cannabis dispensaries to progress in the state. ...
California and Michigan Boost Social Equity in Cannabis Industry with New Funding Initiatives
LOS ANGELES- In a significant move to bolster social equity within the cannabis industry, both California and Michigan have recently taken steps to channel more funding into social equity cannabis companies. California is set to ...
Clearmind Medicine Inc Reports Promising Results in Pre-Clinical Trial for Combination Therapy
LOS ANGELES- Clearmind Medicine Inc has announced the results of its pre-clinical trial involving a combination therapy, marking a significant step in the development of treatments for addictions, obesity, metabolic disorders, and depression. The trial ...
RIV Capital’s Ambitious Transition to Adult-Use Cannabis Sales in New York
LOS ANGELES- RIV Capital, a Toronto-based cannabis investment firm, has navigated a turbulent path in its growth story, particularly in the New York market. Initially setting up as one of the few medical cannabis operators ...
Health Canada Approves Jazz Pharmaceuticals’ Epidiolex
NEW YORK- Canada's federal health regulator, Health Canada, has recently approved Epidiolex, a cannabinoid-based medicine developed by Jazz Pharmaceuticals Canada. This approval positions Epidiolex as a supplementary therapy for certain rare and severe forms of ...
Record Sales on Green Wednesday Signal Booming Cannabis Market
LOS ANGELES- The cannabis industry experienced a significant surge in sales on Green Wednesday, the day before Thanksgiving, marking it as a high-point in annual cannabis commerce. Jane Technologies reported recreational cannabis sales totaling an ...
Arkansas and Rhode Island Cannabis Markets
LOS ANGELES- October 2023 witnessed a modest reduction in medical cannabis sales in Arkansas, reaching $22.5 million, a slight decrease from the same period in 2022. This data, sourced from the state's Department of Finance ...
Wisconsin Legislators Advocate for Veterans’ Access to Psilocybin Therapy Amid National Psychedelic Research Surge
LOS ANGELES- In a groundbreaking move, Wisconsin lawmakers are pushing for enhanced access to psilocybin, a psychedelic compound found in magic mushrooms, for military veterans suffering from post-traumatic stress disorder (PTSD). This bipartisan bill represents ...
Irwin Naturals Inc. Reports Financial Performance in Q3 2023
LOS ANGELES- Irwin Naturals Inc, a key player in the cannabis and mental health sectors, recently disclosed its financial results for the third quarter of fiscal 2023, ending September 30, 2023. The report presents a complex ...
